Shares in Verve Therapeutics ( VERV -0.54%) soared 80.5% this week on the news of an agreement for Eli Lilly ( LLY -2.54%) to ...

Verve's top drug, Verve-102, is designed to target a gene called PCSK9, which is associated with heart health and cholesterol levels.

Eli Lilly (LLY) is a pharmaceutical company that focuses on cardiometabolic health, neuroscience, oncology, and immunology.

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

The National Institutes of Health is undertaking an extended study of the health effects that East Palestine, Ohio, residents ...

A dramatic pullback in public biotech investment catalyzed by economic and regulatory upheaval is putting even more stress on ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations ...